Monitoring Bisphosphonate Therapy: Key Tests and What They Mean
Published: Apr 29, 2024
Medically reviewed by Jerome Albert Ecker | MD, Assistant Professor of Medicine, Duke University - Durham, NC on April 29th, 2024.
Monitoring the effectiveness and safety of bisphosphonate therapy is crucial for optimal osteoporosis management. Several tests help doctors assess how well the treatment is working and detect any potential issues.
Contents
Bone Mineral Density (BMD) Tests
The primary way to monitor bisphosphonate effectiveness is through bone mineral density (BMD) tests. These are typically done using dual-energy X-ray absorptiometry (DXA) scans. BMD tests are usually performed before starting treatment, then every 1-2 years thereafter. Stable or improving BMD indicates the treatment is working. A significant decrease in BMD may signal a need to reevaluate the treatment plan.
Bone Turnover Markers
Blood or urine tests for bone turnover markers can provide additional insights. These markers, such as C-terminal telopeptide (CTX), show how quickly bone is being broken down or built up. A decrease in these markers after starting bisphosphonates suggests the medication is effectively slowing bone loss. These tests are sometimes used to assess early response to treatment or adherence to therapy.
Kidney Function Tests
Since bisphosphonates are eliminated by the kidneys, monitoring kidney function is important. This typically involves blood tests to measure creatinine levels and estimate glomerular filtration rate (eGFR). These tests are especially crucial for patients receiving intravenous bisphosphonates or those with pre-existing kidney issues. Significant changes in kidney function may require adjusting or stopping bisphosphonate therapy.
Frequently Asked Questions
Typically every 1-2 years while on bisphosphonate therapy.
Yes, bone turnover markers can indicate early treatment response.
Yes, kidney function should be monitored periodically.
Your doctor may reevaluate your treatment plan.
Key Takeaways
Regular monitoring ensures you're getting the most benefit from your bisphosphonate therapy while minimizing risks.
Ready to schedule your next monitoring tests? Reach out to Doctronic to stay on top of your bone health.Related Articles
References
Diez-Perez A, et al. Osteoporos Int. 2012;23:2769-2788.
Vasikaran S, et al. Osteoporos Int. 2011;22:391-420.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.